As a global leader in digital therapeutics, we combine the power of AI with wearables data to enable personalized care. Biofourmis is a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. We are pioneering an entirely new category of medicine, by developing clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Biofourmis has built Biovitals®, a highly sophisticated personalized AI-powered health analytics platform that predicts clinical exacerbation in advance of a critical event, which is the backbone of their digital therapeutics’ product pipeline across multiple therapeutic areas—including heart failure, oncology, acute coronary syndrome, COPD and chronic pain. Biofourmis utilizes machine learning, integrated technology, and an FDA-cleared analytics engine to streamline connections between patients and care teams, leading to better outcomes for all. Care teams stay with patients after discharge and in between office visits with an easy-to-use platform that provides personalized treatment plans for immediate medical needs and chronic conditions. Improve clinical outcomes by using continuous patient data and FDA-cleared analytics to provide care teams vital insights to take action. Advance drug development and develop digital therapies that work in conjunction with high-value drugs to improve efficacy. Reduce healthcare costs and readmission rates with platforms that deliver hospital-level care and attention in a patient’s home.